IDEXX Laboratories (IDXX) continues to perform well, outperforming the healthcare sector in the market. Many investment and asset management companies are noticing and adjusting their position on the company. Notable companies such as
Plato Investment Management Ltd,
Anderson Financial Strategies LLC, and the
Goldman Sachs Group Inc have all acquired significant stock holdings in IDXX. Despite a few companies, like
Alliancebernstein L.P and
Voleon Capital Management LP, decreasing their position, other companies have opted to buy new stakes altogether. The company's revenue growth is largely attributed to strong pet and water business trends, which led to raised annual revenue guidance. IDXX has maintained strong momentum, and
Q2 earnings have confirmed consistent revenue and EPS growth. Its financial performance has led to many investors betting on its long-term performance. Additionally, its role as a global pet healthcare leader has brought significant attention, with the company scheduled to present at
Morgan Stanley's 23rd Healthcare Conference.
Idexx Laboratories IDXX News Analytics from Mon, 03 Feb 2025 08:00:00 GMT to Sat, 13 Sep 2025 17:37:58 GMT -
Rating 8
- Innovation 7
- Information 7
- Rumor 1
